Clinical Trial Update: Growth Hormone Treatment in Patients With Aggrecan (ACAN) Deficiency [Phase 1, Phase 2]

View source ↗

Summary

This Phase 1/2 trial of Growth Hormone (somatropin) in patients with Aggrecan (ACAN) deficiency causing short stature has completed enrollment and posted result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Short Stature

Drugs mentioned

• Somatropin (somatropin)

Snippet

Sponsor: Children's Hospital Medical Center, Cincinnati | Conditions: Short Stature | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2024-07-30